Jonathan Perlin, CEO of the Joint Commisssion
As I write this article, I am recovering from a power outage that lasted nearly two days due to trees downed by record winds created by the atmospheric…
Georgia policymakers, county officials and the NAACP are asking the federal government to investigate Wellstar Health System’s closure of two Atlanta-area hospitals in predominantly Black neighborhoods.
The latest request came from the Fulton County Commission…
FDA approval of Pfizer nasal spray migraine drug Zavzpret last week means a $475 million payday for Royalty Pharma. The payment stems from a financing deal Pfizer inherited when it acquired rights to the…
Continue Reading
The Food and Drug Administration’s Dr. Robert Califf called on insurers Thursday to help ensure that studies on new drugs in the accelerated approval pathway are still completed.
“I don’t think it’s just a matter…
What You Should Know:– Accenture published Fast-Forwarding Healthcare through Data Collaboratives Report to discover how best health ecosystem players access data to fast-forward healthcare.– Data generated by technical and scientific advances, like connected health…
Continue Reading
At the MedCity INVEST conference at the Ritz Carlton in Chicago May 22-24, a panel will focus on violence against healthcare professionals. It’s an unfortunate trend that is on the rise, spurred by misinformation…
Continue Reading
What You Should Know:– ObvioHealth and Mi-Helper, Inc. announce a partnership to conduct a decentralized clinical trial for a non-invasive neuromodulation device for the treatment of migraines. The randomized controlled trial will be fully remote,…
Continue Reading
What You Should Know:– Small hospitals are changing their EMRs and patient accounting systems at a greater rate than that of their large-hospital counterparts. Most market selection energy is going to Oracle Health (Cerner),…
Continue Reading
New medications take too long to get into the hands of people who need them – a decade, on average. The leading cause of delays is finding patients for clinical trials, but it shouldn’t…
Continue Reading
Vaccine developer Vaxart contends its pill vaccinations against Covid-19 will be preferable to patients, and potentially more effective than currently available injections. But a different virus offers the biotech a clearer and faster path…
Continue Reading
